doi: 10.1038/302716a0 5 HeinrichGGrosPHabenerJF
Thus, GLP-1R-targeted nanotherapies for T2DM are primarily designed to enhance therapeutic convenience through oral or infrequent dosing and to improve efficacy through targeted pancreatic delivery, with the potential to substantially improve clinical outcomes
Common Side Effects: Nausea, vomiting, diarrhea, and constipation
GLP-1 medications work gradually, with optimal effects developing over weeks to months
GLP-1 becomes the key to unlocking your bodys potential, and with our expert guidance, youll navigate the journey towards a healthier, happier you
1 Introduction Until recently, the worldwide increase in obesity, characterized by a body mass index (BMI) exceeding 30 kg/m 2 , was widely considered an inevitable trend with limited hope for meaningful advances in pharmacological treatment